Title: An Alternative Splicing Signature in Human Crohn’s Disease
Version: 6 Date: 19 Oct 2021
Reviewer's report:
As the authors mentioned, due to the budget limitation and the sample limitation,  a western blot
to validate the impact of 3’UTR change on
protein expression wasn't performed. I hope the authors can continue their work in the future
to further validate these preliminary results. Moreover, this should be listed the as a major
limitation in their manuscript which warrant further study.
Title: An Alternative Splicing Signature in Human Crohn’s Disease
Version: 6 Date: 19 Oct 2021
Reviewer's report:
As the authors mentioned, due to the budget limitation and the sample limitation,  a western blot
to validate the impact of 3’UTR change on
protein expression wasn't performed. I hope the authors can continue their work in the future
to further validate these preliminary results. Moreover, this should be listed the as a major
limitation in their manuscript which warrant further study.
Please review this paper.
user
Title: An Alternative Splicing Signature in Human Crohn’s Disease
Version: 6 Date: 19 Oct 2021
Reviewer's report:
As the authors mentioned, due to the budget limitation and the sample limitation,  a western blot
to validate the impact of 3’UTR change on
protein expression wasn't performed. I hope the authors can continue their work in the future
to further validate these preliminary results. Moreover, this should be listed the as a major
limitation in their manuscript which warrant further study.
assistant